Stiff person syndrome (SPS) is a rare autoimmune disorder that causes progressive muscle stiffness and painful spasms, primarily in the trunk and limbs. It was long thought to affect roughly 1 to 2 people per million, but a 2024 population-based study published in Neurology found a higher prevalence of about 1 in 47,500 people, suggesting the condition has been significantly underdiagnosed. The average age of onset is around 50, though it can appear earlier or later.
What Happens in the Body
Your muscles are constantly receiving two types of signals from the nervous system: signals to contract and signals to relax. The relaxation side depends heavily on a chemical messenger called GABA, which acts like a brake on nerve activity. In most people with SPS, the immune system produces antibodies that attack the enzyme responsible for making GABA. Without enough of this calming chemical, the “brakes” on muscle contraction stop working properly. The result is muscles that stay contracted when they should be relaxed, and nerve signals that fire too easily, triggering sudden, intense spasms.
This process doesn’t cause visible damage to the brain or spinal cord on imaging scans. Instead, it disrupts the chemical balance of the nervous system, which is part of why diagnosis can be so difficult and delayed.
Three Forms of the Condition
SPS exists on a spectrum with several recognized forms. Classic SPS is by far the most common, accounting for 70 to 80% of cases. It causes stiffness that typically starts in the lower back and abdomen, then gradually spreads to the legs. Over time, the rigid posture can produce an exaggerated curve of the lower spine.
Partial variants, sometimes called stiff limb syndrome, confine stiffness to one or two limbs rather than the trunk. Jerky SPS, a cerebellar variant involving coordination problems, and forms associated with seizures or abnormal postures have also been described.
The most severe form is progressive encephalomyelitis with rigidity and myoclonus (PERM). People with PERM experience the same axial and limb rigidity as classic SPS but also develop widespread involuntary jerking movements and significant disruption of automatic body functions like blood pressure, heart rate, and temperature regulation.
What Spasms Feel Like and What Triggers Them
The hallmark of SPS is not just stiffness but episodes of sudden, intense muscle spasms that can be extraordinarily painful. These spasms layer on top of the baseline rigidity and can be strong enough to cause falls or, in severe cases, fractures. They tend to come in waves and can last seconds to minutes.
What makes SPS particularly disruptive is how easily these spasms can be triggered. Common triggers include unexpected or loud noises, light physical touch, and emotional stress or anxiety. Because the startle response itself can set off a spasm, many people with SPS develop significant anxiety about being in unpredictable environments, which creates a cycle where the emotional distress itself worsens symptoms. Over time, the fear of triggering a spasm can become as limiting as the spasms themselves.
Conditions That Often Appear Alongside SPS
Because SPS is autoimmune, it frequently coexists with other autoimmune conditions. Up to 35% of people with SPS also have type 1 diabetes, which may appear months to years before SPS symptoms begin or develop shortly after stiffness starts. This overlap makes sense because the same antibodies that attack GABA production in the nervous system also target insulin-producing cells in the pancreas.
Other associated conditions include autoimmune thyroid disease, pernicious anemia (a B12 absorption problem), vitiligo, and celiac disease. A small but important subset, roughly 5 to 10% of all SPS cases, turns out to be paraneoplastic, meaning the syndrome is triggered by an underlying cancer. Breast cancer is the most common culprit, though lung, colon, and thymus cancers and Hodgkin’s lymphoma have all been linked. These paraneoplastic cases involve a different antibody and may require treatment of the cancer itself to improve neurological symptoms.
How SPS Is Diagnosed
Diagnosis relies on a combination of clinical symptoms, blood tests, and electrical studies of the muscles. The blood test looks for high levels of antibodies against the GABA-producing enzyme. Most people with classic SPS test positive, and these antibodies can also be detected in spinal fluid, where GABA levels are often measurably reduced.
An electromyography (EMG) test, which uses small needles to record electrical activity in muscles, shows a characteristic pattern: continuous muscle firing in the stiff areas even when the person is trying to relax. This activity increases when the opposing muscle group contracts, a pattern that helps distinguish SPS from other causes of stiffness.
Because the condition is so rare, many people see multiple specialists over several years before receiving a correct diagnosis. Symptoms can initially be mistaken for anxiety disorders, Parkinson’s disease, multiple sclerosis, or fibromyalgia.
First-Line Treatment: Managing Stiffness and Spasms
Treatment starts with medications that boost the very chemical the disease depletes. Benzodiazepines, which enhance GABA’s calming effect on the nervous system, are the standard first-line therapy. Diazepam is the most commonly used, and effective doses are often considerably higher than what would be prescribed for anxiety, sometimes reaching 60 mg per day. These doses would be heavily sedating for most people, but the GABA deficit in SPS means patients can often tolerate them with less drowsiness than expected.
When benzodiazepines alone aren’t enough, a muscle relaxant called baclofen is typically added as second-line therapy. It works through a different mechanism on the same GABA pathways, and the two medications can complement each other.
Immunotherapy for Moderate to Severe Cases
Because SPS is fundamentally an immune system problem, many patients also need treatment that targets the immune response directly. Intravenous immunoglobulin (IVIg) is the most studied option. It involves receiving concentrated antibodies from donated blood through an IV, typically once a month.
A long-term study of 36 patients treated with monthly IVIg found that 67% experienced a clinically meaningful improvement, with benefits sustained over a median period of about 3.3 years. Recent systematic reviews have recommended IVIg as a first-line immune therapy for classic SPS, particularly for people whose symptoms don’t respond well enough to benzodiazepines and baclofen alone.
Despite this, there is no standardized treatment algorithm for SPS. Clinical decisions are still largely guided by expert opinion, and response to therapy varies significantly from person to person. What works well for one patient may do little for another, which often means a period of trial and adjustment.
Physical Therapy and Daily Life
Certain types of physical therapy can help manage stiffness and maintain mobility, though the approach needs to be tailored carefully. Aquatic therapy is frequently recommended because the warmth and buoyancy of water can relax muscles without triggering spasms. Deep tissue massage, heat therapy, and ultrasound therapy may also provide relief at various stages of the disease.
The key consideration is that aggressive stretching or unexpected movements during therapy can provoke the very spasms treatment is trying to prevent. A therapist familiar with SPS will work within the patient’s comfort zone, progressing slowly and avoiding sudden stimuli. For many people with SPS, the practical challenge isn’t just the physical stiffness but the way it reshapes daily routines: navigating crowded spaces becomes stressful, sleep is disrupted by nocturnal spasms, and the unpredictability of symptoms can make planning difficult.